CVSI · CV Sciences, Inc.

The option is durational-based. No option shares are vested on the date of grant. The option shares vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from February 18, 2025, provided, that there has not been a termination of service as of such date. In no event will any unvested portion of the option vest or become exercisable for any additional option shares after the termination of service.

The option is durational-based. No option shares are vested on the date of grant. The option shares vest and become exercisable on April 30, 2026, provided, that there has not been a termination of service as of such date. In no event will any unvested portion of the option vest or become exercisable for any additional option shares after a termination of service.

The option is durational-based. No option shares are vested on the date of grant. The option shares vest and become exercisable on April 30, 2026, provided, that there has not been a termination of service as of such date. In no event will any unvested portion of the option vest or become exercisable for any additional option shares after a termination of service.

The option is durational-based. No option shares are vested on the date of grant. The option shares vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from February 18, 2025, provided, that there has not been a termination of service as of such date. In no event will any unvested portion of the option vest or become exercisable for any additional option shares after the termination of service.

The option is durational-based. No option shares are vested on the date of grant. The option shares vest and become exercisable on April 30, 2025, provided, that there has not been a termination of service as of such date. In no event will any unvested portion of the option vest or become exercisable for any additional option shares after a termination of service.

The option is durational-based. No option shares are vested on the date of grant. The option shares vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from June 20, 2024, provided, that there has not been a termination of service as of such date. In no event will any unvested portion of the option vest or become exercisable for any additional option shares after a termination of service.

The option is durational-based. No option shares are vested on the date of grant. The option shares vest and become exercisable on April 30, 2025, provided, that there has not been a termination of service as of such date. In no event will any unvested portion of the option vest or become exercisable for any additional option shares after a termination of service.

The option is durational-based. No option shares are vested on the date of grant. The option shares vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from June 20, 2024, provided, that there has not been a termination of service as of such date. In no event will any unvested portion of the option vest or become exercisable for any additional option shares after a termination of service.

The option is durational-based. No option shares are vested on the date of grant. The option shares vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from March 15, 2023, provided, that there has not been a termination of service as of such date. In no event will any unvested portion of the option vest or become exercisable for any additional option shares after a termination of service.

The option is durational-based. No option shares are vested on the date of grant. The option shares vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from March 15, 2023, provided, that there has not been a termination of service as of such date. In no event will any unvested portion of the option vest or become exercisable for any additional option shares after a termination of service.

The option is durational based. Fifty percent (50%) of the option shares vest and become exercisable on each of October 21, 2023 and October 21, 2024, provided, that there has not been a termination of service as of such date. In no event will the option become exercisable for any additional option shares after a termination of service.

The option is durational based. Fifty (50%) of the option shares vest and become exercisable on August 12, 2023 and August 12, 2024, provided, that there has not been a termination of service as of such date. In no event will any unvested portion of the option vest or become exercisable for any additional option shares after a termination of service.

On March 30, 2022, the stock options were cancelled by mutual agreement of the reporting person and the issuer. The reporting person received an aggregate of $100 as consideration for the cancellation.

The option is durational based. All option shares were vested and exercisable on the date of cancellation.

On March 30, 2022, the stock options were cancelled by mutual agreement of the reporting person and the issuer. The reporting person received an aggregate of $100 as consideration for the cancellation.

The option is durational based. 375,000 option shares were vested and exercisable on the date of cancellation. Twenty-five (25%) of the option shares were scheduled to vest and become exercisable on September 1, 2022 and March 1, 2023, provided, that there was no termination of service as of such date.

On March 30, 2022, the stock options were cancelled by mutual agreement of the reporting person and the issuer. The reporting person received an aggregate of $100 as consideration for the cancellation.

The option is durational based. 750,000 option shares were vested and exercisable on the date of cancellation. Twenty-five (25%) of the option shares were scheduled to vest and become exercisable on September 1, 2022 and March 1, 2023, provided, that there was no termination of service as of such date.

On March 30, 2022, the stock options were cancelled by mutual agreement of the reporting person and the issuer. The reporting person received an aggregate of $100 as consideration for the cancellation.

The option is durational based. All option shares were vested and exercisable on the date of cancellation.

On March 30, 2022, the stock options were cancelled by mutual agreement of the reporting person and the issuer. The reporting person received an aggregate of $100 as consideration for the cancellation.

The option is performance-based. 500,000 option shares were vested and exercisable on the date of cancellation. The remaining option shares were scheduled to vest and become exercisable in accordance with certain performance criteria which were not met at the date of cancellation.

On March 30, 2022, the stock options were cancelled by mutual agreement of the reporting person and the issuer. The reporting person received an aggregate of $100 as consideration for the cancellation.

The option is durational based. All option shares were vested and exercisable on the date of cancellation.

On March 30, 2022, the stock options were cancelled by mutual agreement of the reporting person and the issuer. The reporting person received an aggregate of $100 as consideration for the cancellation.

The option is durational based. All option shares were vested and exercisable on the date of cancellation.

On March 30, 2022, the stock options were cancelled by mutual agreement of the reporting person and the issuer. The reporting person received an aggregate of $100 as consideration for the cancellation.

The option is durational based. All option shares were vested and exercisable on the date of cancellation.

On March 30, 2022, the stock options were cancelled by mutual agreement of the reporting person and the issuer. The reporting person received an aggregate of $100 as consideration for the cancellation.

The option was fully vested on the date of grant.

On March 30, 2022, the stock options were cancelled by mutual agreement of the reporting person and the issuer. The reporting person received an aggregate of $100 as consideration for the cancellation.

On March 30, 2022, the stock options were cancelled by mutual agreement of the reporting person and the issuer. The reporting person received an aggregate of $100 as consideration for the cancellation.

The option is durational based. All option shares were vested and exercisable on the date of cancellation.

On March 30, 2022, the stock options were cancelled by mutual agreement of the reporting person and the issuer. The reporting person received an aggregate of $100 as consideration for the cancellation.

The option is durational based. All option shares were vested and exercisable on the date of cancellation.

On March 30, 2022, the stock options were cancelled by mutual agreement of the reporting person and the issuer. The reporting person received an aggregate of $100 as consideration for the cancellation.

The option is performance-based. 250,000 option shares were vested and exercisable on the date of cancellation. The remaining option shares were scheduled to vest and become exercisable in accordance with certain performance criteria which were not met at the date of cancellation.

On March 30, 2022, the stock options were cancelled by mutual agreement of the reporting person and the issuer. The reporting person received an aggregate of $100 as consideration for the cancellation.

The option is durational based. All option shares were vested and exercisable on the date of cancellation.

The option is durational-based. All 275,000 option shares vest and become exercisable on April 15, 2022, provided, that there has not been a termination of service as of such date. In no event will any unvested portion of the option vest or become exercisable for any additional option shares after a termination of service.

The option is durational-based. All 275,000 option shares vest and become exercisable on April 15, 2022, provided, that there has not been a termination of service as of such date. In no event will any unvested portion of the option vest or become exercisable for any additional option shares after a termination of service.

The option is durational-based. All 275,000 option shares vest and become exercisable on April 15, 2022, provided, that there has not been a termination of service as of such date. In no event will any unvested portion of the option vest or become exercisable for any additional option shares after a termination of service.

The option is durational-based. All 275,000 option shares vest and become exercisable on April 15, 2022, provided, that there has not been a termination of service as of such date. In no event will any unvested portion of the option vest or become exercisable for any additional option shares after a termination of service.

The shares were purchased in multiple transactions, each at a price of $0.38 per share.

The option is durational-based. No option shares are vested on the date of grant. Twenty-five percent (25%) of the option shares vest and become exercisable on each of the following dates: September 1, 2021, March 1, 2022, September 1, 2022, and March 1, 2023, provided, that there has not been a termination of service as of such date. In no event will any unvested portion of the option vest or become exercisable for any additional option shares after a termination of service.

The option is durational-based. No option shares are vested on the date of grant. Twenty-five percent (25%) of the option shares vest and become exercisable on each of the following dates: September 1, 2021, March 1, 2022, September 1, 2022, and March 1, 2023, provided, however, that there has not been a termination of service as of such date. In no event will the option become exercisable for any additional option shares after a termination of service.

The option is durational-based. No option shares are vested on the date of grant. Twenty-five percent (25%) of the option shares vest and become exercisable on each of the following dates: September 1, 2021, March 1, 2022, September 1, 2022, and March 1, 2023, provided, that there has not been a termination of service as of such date. In no event will any unvested portion of the option vest or become exercisable for any additional option shares after a termination of service.

As of the date of this filing, the reporting person owns a total of 1,986,722 shares of common stock of the issuer, of which, the reporting person indirectly owns 174,662 shares of common stock of the issuer through Aegean Limited LLC, and directly owns 1,812,060 shares of common stock of the issuer.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.619 to $0.64 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.60 to $0.62 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.562134 to $0.59 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

As of the date of this filing, the reporting person owns a total of 2,203,322 shares of common stock of the issuer, of which, the reporting person indirectly owns 174,662 shares of common stock of the issuer through Aegean Limited LLC, and directly owns 2,028,660 shares of common stock of the issuer.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.55 to $0.56 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.601 to $0.619 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

As of the date of this filing, the reporting person owns a total of 2,353,462 shares of common stock of the issuer, of which, the reporting person indirectly owns 174,662 shares of common stock of the issuer through Aegean Limited LLC, and directly owns 2,178,800 shares of common stock of the issuer.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.6116 to $0.624 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.4951 to $0.719 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.57 to $0.59 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

As of the date of this filing, the reporting person owns a total of 2,853,662 shares of common stock of the issuer, of which, the reporting person indirectly owns 174,662 shares of common stock of the issuer through Aegean Limited LLC, and directly owns 2,679,000 shares of common stock of the issuer.

The shares are directly held by Aegean Limited LLC, an entity owned by the reporting person's spouse. The reporting person disclaims beneficial ownership of such shares except to the extent of the reporting person's pecuniary interest therein, if any.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.58 to $0.59 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The shares are directly held by Aegean Limited LLC, an entity owned by the reporting person's spouse. The reporting person disclaims beneficial ownership of such shares except to the extent of the reporting person's pecuniary interest therein, if any.

The option is durational-based. 150,000 option shares vest and become exercisable on June 16, 2021, provided, however, that there has not been a termination of service as of such date. In no event will the option become exercisable for any additional option shares after a termination of service.

The option is durational-based. 150,000 option shares vest and become exercisable on June 16, 2021, provided, however, that there has not been a termination of service as of such date. In no event will the option become exercisable for any additional option shares after a termination of service.

The option is durational-based. 150,000 option shares vest and become exercisable on June 16, 2021, provided, however, that there has not been a termination of service as of such date. In no event will the option become exercisable for any additional option shares after a termination of service.

The option is durational-based. 40,000 option shares vested on the date of grant and the remaining 150,000 option shares vest and become exercisable on June 16, 2021, provided, however, that there has not been a termination of service as of such date. In no event will the option become exercisable for any additional option shares after a termination of service.

The option is durational-based. 80,000 option shares vested on the date of grant and the remaining 150,000 option shares vest and become exercisable on June 16, 2021, provided, however, that there has not been a termination of service as of such date. In no event will the option become exercisable for any additional option shares after a termination of service.